Class I molecules of the major histocompatibility complex (MHC) consist of a highly polymorphic heavy chain complexed to beta2, microglobulin (beta2m). Class I molecules are expressed on virtually all cell types. Their sole function is to bind antigens and present them to T cell bearing CD8 molecules (Tcd8+). Tcd8+ play a critical role in eradicating intracellular pathogens and tumors. They are also a significant cause of immunopathology, being involved in organ rejection and autoimmune diseases. There has been rapid progress in understanding the physical nature of the antigen-class I complex and in how antigens are generated and become associated with class I molecules in cells. It is now apparent that antigens derived from a cytosolic pool of proteins are translocated into an exocytic compartment by MHC encoded transporter complex. Once transported from the cytosol, antigens bind to class I molecules and are transported to the cell surface. Continuing our studies on the assembly and trafficking of MHC class I molecules in the past year we: 1) obtained the first direct evidence that peptides associate with class I molecules in an early exocytic compartment, 2) genetically engineered a class I molecule retained in the endoplasmic reticulum (ER) that will provide finer resolution into the identity of the compartment in which antigen association occurs, 3) developed a fluorescent derivative of an antigenic peptide that retains the capacity to bind class I molecules and offers the promise of studying class I assembly and transport in living cells, 4) found that cells differentially internalize from the cell surface two different types of class I molecules, and made preliminary findings that suggest that cell surface class I molecules can be returned to the Golgi complex.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000542-05
Application #
3790801
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Hickman, Heather D; Mays, Jacqueline W; Gibbs, James et al. (2018) Influenza A Virus Negative Strand RNA Is Translated for CD8+ T Cell Immunosurveillance. J Immunol 201:1222-1228
Wei, Jiajie; Zanker, Damien; Di Carluccio, Anthony R et al. (2017) Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands. J Immunol 198:3835-3845
Hickman, Heather D; Reynoso, Glennys V; Ngudiankama, Barbara F et al. (2013) Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. Cell Host Microbe 13:155-68
David, Alexandre; Bennink, Jack R; Yewdell, Jonathan W (2013) Emetine optimally facilitates nascent chain puromycylation and potentiates the ribopuromycylation method (RPM) applied to inert cells. Histochem Cell Biol 139:501-4
Stewart-Jones, Guillaume; Wadle, Andreas; Hombach, Anja et al. (2009) Rational development of high-affinity T-cell receptor-like antibodies. Proc Natl Acad Sci U S A 106:5784-8
Haeryfar, S M Mansour; Hickman, Heather D; Irvine, Kari R et al. (2008) Terminal deoxynucleotidyl transferase establishes and broadens antiviral CD8+ T cell immunodominance hierarchies. J Immunol 181:649-59
Lev, Avital; Takeda, Kazuyo; Zanker, Damien et al. (2008) The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity 28:787-98
Yewdell, Jonathan W (2007) Plumbing the sources of endogenous MHC class I peptide ligands. Curr Opin Immunol 19:79-86
Pardigon, Nathalie; Takeda, Kazuyo; Saunier, Bertrand et al. (2006) CD8 alpha alpha-mediated intraepithelial lymphocyte snatching of thymic leukemia MHC class Ib molecules in vitro and in vivo. J Immunol 177:1590-8
Yewdell, Jonathan W; Haeryfar, S M Mansour (2005) Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. Annu Rev Immunol 23:651-82

Showing the most recent 10 out of 26 publications